http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105561301-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y301-01004 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-465 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-46 |
| filingDate | 2016-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2020-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2020-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-105561301-B |
| titleOfInvention | Application of clonorchis sinensis secreted phospholipase A2 protein in preparing tumor treatment medicine |
| abstract | The invention belongs to the technical field of biology, and particularly relates to application of clonorchis sinensis secreted phospholipase A2 protein in preparation of a tumor treatment drug. The invention, after extensive and intensive research, discovers the clonorchis sinensis secreted phospholipase A2 protein for the first time Cs sPLA2 protein) has obvious inhibiting effect on the growth of human bile duct cancer FRH cells (hepatic portal cholangiocarcinoma), and the inhibiting rate is as high as over 86%. That is, the present invention has found for the first time Cs New application of sPLA2 protein in preparation of medicine for treating bile duct cancer. |
| priorityDate | 2016-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 74.